|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Needham on April 29, 2021. The analyst firm set a price target for 26.00 expecting CARA to rise to within 12 months (a possible 81.18% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $14.35 last updated Today at 1:38:15 PM.
There are no upcoming dividends for Cara Therapeutics.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.